CIK 0000010795
- Large accelerated filer
BECTON DICKINSON & CO
Sign in to watch- Ticker
- BDX
- Exchange
- NYSE
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Sep 30
- Incorporated
- NJ
- Entity type
- Operating
- EIN
- 220760120
- Phone
- +1 201-847-6800
- Business address
- ONE BECTON DR, FRANKLIN LAKES, NJ, 07417-1880
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $688,650
- in 4 filings, $689K under 10b5-1 plans
Net −$688,650. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-11-26 | DelOrefice Christopher EVP & CFO | Grant or award | +2,608 | 6,967 | ||
| 2021-11-26 | DelOrefice Christopher EVP & CFO | Grant or award · Stock Appreciation Rights | +18,638 | 18,638 | ||
| 2021-11-26 | Lim James C Executive Vice President | Grant or award | +893 | 20,661 | ||
| 2021-11-16 | Goette Roland EVP and President, EMEA | Exercise or conversion | +3,055 | $72.12 | $220K | 11,287 |
| 2021-11-16 | Goette Roland EVP and President, EMEA | Shares withheld for taxes | −1,914 | $244.11 | $467K | 9,373 |
| 2021-11-16 | Goette Roland EVP and President, EMEA | Exercise or conversion · Stock Appreciation Rights | −3,055 | 0 | ||
| 2021-11-02 | Jones Christopher Ian Montague Director | Grant or award · Rights to Common Stock Under 1996 Directors Deferral Plan | +112 | $243.11 | $27K | 8,093 |
| 2021-10-21 | Byington Carrie L Director | Grant or award | +221 | 221 | ||
| 2021-09-08 | Spoerel Thomas J VP Controller & Chief Acct Off | Sale | −267 | $260.00 | $69K | 1,018 |
| 2021-09-08 | Hickey David EVP & President, Life Sciences | Sale | −500 | $260.00 | $130K | 3,586 |
| 2021-09-08 | RIMEL REBECCA W Director | Sale | −500 | $260.00 | $130K | 10,618 |
| 2021-09-07 | DelOrefice Christopher EVP & CFO | Grant or award | +4,359 | 4,359 | ||
| 2021-09-04 | Hickey David EVP & President, Life Sciences | Shares withheld for taxes | −268 | 4,086 | ||
| 2021-09-03 | Lim James C Executive Vice President | Exercise or conversion | +14,584 | $134.73 | $2.0M | 34,352 |
| 2021-09-03 | Lim James C Executive Vice President | Returned to the company | −7,628 | $257.44 | $2.0M | 26,724 |
| 2021-09-03 | Lim James C Executive Vice President | Sale | −6,956 | $257.44 | $1.8M | 19,768 |
| 2021-09-03 | Lim James C Executive Vice President | Exercise or conversion · Stock Appreciation Rights | −14,584 | 0 | ||
| 2021-09-03 | RIMEL REBECCA W Director | Sale | −500 | $257.10 | $129K | 11,118 |
| 2021-09-02 | RIMEL REBECCA W Director | Sale | −244 | $254.00 | $62K | 11,618 |
| 2021-08-30 | RIMEL REBECCA W Director | Sale | −207 | $252.00 | $52K | 11,862 |
Page 27 of 28 · 548 trades